| 41/83 | US=6 / Quimioterapia Airley R. Histone deacetylase: an epigenetic drug target. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 255-63. ISBN 978-0-470-09254-5. INIBIDORES DE HDAC; HISTONA DEACETILASE; DROGA EPIGENETICA; HDAC; EMBALAGEM DE DNA |
| 42/83 | US=22 / Urologia Peruzzi B, Lattouf JB, Bottaro DP. The role of hepatocyte growth factor pathway signaling in renal cell carcinoma. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 321-34. ISBN 978-1-58829-737-2. FATOR DE CRESCIMENTO HEPATOCITO; C-MET; CARCINOMA DE CELULAS RENAIS; MECANISMOS ONCOGENICOS; DESENVOLVIMENTO DROGA CONTRA O CANCER |
| 43/83 | US=8 / Laboratório Kager L, Evans WE. Pharmacogenomics and hematologic diseases. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 81-92. ISBN 978-0-443-06715-0. FARMACOGENOMICA; DOENCAS HEMATOLOGICAS; VARIACAO DE SEQUENCIA HUMANA; POLIMORFISMOS DE NUCLEOTIDEO UNICO; FENOTIPOS; HAPLOTIPO; DESEQUILIBRIO DE LIGACAO; VARIACOES GENETICAS; RESPOSTA A DROGA; FARMACOGENETICA; FARMACOGENOMICA; OTIMIZACAO DA TERAPEUTICA MEDICAMENTOSA; METABOLISMO DE DROGAS; TRANSPORTADORES DE DROGAS; DESENVOLVIMENTO DE DROGAS |
| 44/83 | US=33 / Dor/Paliativo Hardy JR, Quigley C, Ross JR. Opioid rotation. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 301-12. ISBN 978-0-19-923664-0. ROTACAO DE OPIOIDES; MUDAR DE ROTA; ROTACAO EM GERAL; ROTACAO DE DROGA ESPECIFICA |
| 45/83 | US=8 / Laboratório Warkentin TE. Thrombocytopenia due to platelet destruction and hypersplenism. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 2113-31. ISBN 978-0-443-06715-0. TROMBOCITOPENIA DEVIDO A DESTRUICAO PLAQUETARIA; HIPERESPLENISMO; PACIENTE TROMBOCITOPENICO; SINDROME TROMBOCITOPENICA INDUZIDA POR DROGAS; TROMBOCITOPENIA INDUZIDA POR HEPARINA; TROMBOCITOPENIA IMUNE INDUZIDA POR DROGA; TROMBOCITOPENIA AUTO-IMUNE INDUZIDA POR DROGA; TROMBOCITOPENIA INCIDENTAL DA GRAVIDEZ; PRE-ECLAMPSIA; ECLAMPSIA; INFECCAO; LUPUS ERIMATOSO SISTEMICO (LES); SINDROME ANTIFOSFOLIPIDE; SINDROME DE ATIVACAO MACROFAGICA; DOENCA CARDIOVASCULAR |
| 46/83 | US=60 / Biol/Mol Yarde DN, Tao J. Apoptosis and the tumor microenvironment in hematologic malignancies. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 193-218. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; RESISTENCIA A DROGA; LEUCEMIA; LINFOMA; MIELOMA MULTIPLO; MICROAMBIENTE DO TUMOR |
| 47/83 | US=64 / Biol/Mol Weissig V, D´Souza GGM, Cheng SM, Boddapati S. Mitochondrial nanotechnology for cancer therapy. In: Singh KK, Costello LC. Mitochondria and cancer. New York: Spriger, 2009. p. 265-79. ISBN 978-0-387-84834-1. NANOTECNOLOGIA MITOCONDRIAL PARA TERAPIA DE CANCER; NANOTECNOLOGIA E TERAPIA DO CANCER; BARREIRAS CITOSOLICOS PARA A ENTREGA DA DROGA MITOCONDRIAL; MITOCONDRIAS-ALVO SISTEMAS DE ENTREGA NANODRUG; NANOPARTICULAS DE OURO ADEQUADO PARA A MITOCONDRIA |
| 48/83 | US=66 / Biol/Mol Punchihewa C, Yang D. Therapeutic targets and drugs II: G-quadruplex and G-quadruplex inhibitors. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 251-80. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0. ALVOS TERAPEUTICOS E MEDICAMENTOS II; G-QUADRUPLEX E G-QUADRUPLEX INIBIDORES; TELOMERO HUMANO; G-QUADRUPLEX; META DROGA ANTICANCER; G-QUADRUPLEX LIGANTES; POLIMORFISMO ESTRUTURA TELOMERICA G-QUADRUPLEX |
| 49/83 | US=89 / Biol/Mol Jia LJ, Hua ZC. Development of bacterial vectors for tumor-targeted gene therapy. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 131-54. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9. VIAS DE ADMINISTRACAO; ANTI-ANGIOGENESE; VETOR BACTERIANA; TERAPIA GENICA DO CANCER; CITOCINA; EXPRESSAO DO GENE; TERAPIA PRO-DROGA; RNA DE INTERFERENCIA; DIRECIONAMENTO AO TUMOR |
| 50/83 | US=89 / Biol/Mol Jaboin JJ, Han Z, Hallahan DE. Using in vivo biopanning for the development of radiation-guided drug delivery systems. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 285-300. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9. BIOPROSPECCAO; SISTEMA DE ENTREGA DE DROGA; CAMUNDONGOS; EXIBICAO DE FAGO; RADIOSENSIBILIZACAO; RADIOTERAPIA; TRATAMENTO INDUZIDO POR BIOMARCADOR; BACTERIOFAGO T7; CELULAS TUMORAIS |
| 51/83 | US=89 / Biol/Mol Simpson GR, Coffin RS. Construction and characterization of an oncolytic HSV vector containing a fusogenic glycoprotein and prodrug activation for enhanced local tumor control. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 551-64. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9. TERAPIA DO CANCER; GLICOPROTEINA DE MEMBRANA FUSOGENICA (FMG); VIRUS HERPES SIMPLEX TIPO 1 (HSV-1); ONCOLITICOS; TERAPIA DE ATIVACAO PRO-DROGA |
| 52/83 | US=29 / Radioterapia Piehl SL. Pharmacology and drug administration. In: Washington CM, Leaver D. Principles and practice of radiation therapy. 3ªed. Philadelphia: Elsevier Mosby, 2010. p. 247-64. ISBN 978-0-323-05362-4. FARMACOLOGIA E ADMINISTRACAO DE DROGAS; REACCOES ALERGICAS; CHOQUE ANAFILATICO; MEIOS DE CONTRASTE; EFEITO CUMULATIVO; DROGA; INTERACOES MEDICAMENTOSAS; DISPNEIA; DOENCA IATROGENICA; PHARMACODIMANICAS; FARMACOCINETICA; TOLERANCIA; URTICARIA; PUNCAO VENOSA |
| 53/83 | US=10 / Gastro Foghetti D, Landa L. Antibiotic and antithrombotic prophylaxis for pancreatic surgery. In: Siquini W, editor. Surgical treatment of pancreatic diseases. New York: Springer, 2008. p. 239-48. ISBN 978-88-470-0855-7. PROFILAXIA ANTIBIOTICA E ANTITROMBOTICA PARA CIRURGIA PANCREATICA; PROFILAXIA ANTIBIOTICA; PROFILAXIA ANTITROMBOTICA; PROFILAXIA ANTITROMBOTICA MECANICA; DROGA ANTITROMBOTICA PROFILATICO |
| 54/83 | US=108 / Câncer Schepelmann S, Hedley D, Ogilvie LM, Springer CJ. Gene-directed enzyme prodrug therapy. In: Harrington KJ, Vile RG, Pandha HS. Viral therapy of cancer. New Jersey: John Wiley & Sons, 2008. p. 255-76. ISBN 978-0-470-01922-1. TERAPIA GENICA; PRO-DROGA; PRO-FARMACO ATIVADO POR ENZIMA; GANCICLOVIR; TIMIDINA QUINASE; 5-FLUOROCITOSINA; CITOSINA DEAMINASE; CB1954; NITRORREDUTASE; CARBOXIPEPTIDASE G2; OXAZAPHOSPHORINES; CITOCROMO P450; FLUDARABINA; PURINA NUCLEOSIDEO FOSFORILASE; SELENOMETIONINA; METIONINASE; CPT-11; CARBOXILESTERASE; RETROVIRUS; ADENOVIRUS; VACCINIA; VIRUS HERPES SIMPLEX; VIRUS SINDBIS |
| 55/83 | US=11-B / Quimioterapia Goldie JH. Drug resistance. In: Perry MC. The chemotherapy source book. 4th ed. Philadelphia: Wolters Kluwer, 2008. p. 21-9. ISBN 978-0-7817-7328-7. QUIMIOTERAPIA; RESISTENCIA A DROGA; BASES BIOLOGICAS; EXPERIMENTOS; MECANISMOS BIOQUIMICOS; MODELOS MATEMATICOS; RESISTENCIA A RADIACAO; EVASAO DE RESISTENCIA |
| 56/83 | US=11-B / Quimioterapia Barrett BK, Linebaugh JA. Clinical trials. In: Perry MC. The chemotherapy source book. 4th ed. Philadelphia: Wolters Kluwer, 2008. p. 37-43. ISBN 978-0-7817-7328-7. QUIMIOTERAPIA; ENSAIOS CLINICOS; INVESTIGACAO CLINICA; ORCAMENTOS DE ESTUDO; MANUSEIO DE DROGA EXPERIMENTAL |
| 57/83 | US=7 / Farmacologia Wells BG, DiPiro JT, Schwinghammer TL, DiPiro Cecily V. Assessment and nutrition requirements. In: ___. Pharmacotherapy handbook. 7th ed. New York: McGraw-Hill, 2008. p. 647-54. ISBN 978-0-07-148501-2. AVALIACAO E NECESSIDADES NUTRICIONAIS; TRIAGEM NUTRICIONAL; AVALIACAO NUTRICIONAL; MEDIDAS ANTROPOMETRICAS; AVALIACAO DAS NECESSIDADES DE NUTRIENTES; DROGA INTERACOES DE NUTRIENTES |
| 58/83 | US=8 / Dermatologia Edwards L. Diseases and disorders of the anogenitalia of females. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editores. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2008. p. 1107-18. ISBN 978-0-07138076-0. DOENCAS DA ANOGENITALIA FEMININA; ECZEMA; LIQUEN SIMPLES CRONICO; DERMATITE DE CONTATO IRRITATIVA; DERMATITE DE CONTATO ALERGICA; PSORIASE; CANDIDIASE VULVOVAGINAL; LIQUEN ESCLEROSO; FISSURAS VULVARES; LIQUEN PLANO; SINDROME STEVENS-JOHNSON; NECROLISE EPIDERMICA TOXICA; ERITEMA MULTIFORME BOLHOSA; PENFIGOIDE CICATRICIAL; PENFIGO VULGAR; ERUPCAO FIXA POR DROGA; AFTAS; DOENCA DE CROHN; HIDRADENITE SUPURATIVA; VULVODINIA; DISESTESIA VULVAR; PRURIDO VULVAR |
| 59/83 | US=8 / Dermatologia Shear NH, Knowles SR, Sullivan JR, Shapiro L. Cutaneous reactions to drugs. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editores. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2008. p. 1330-7. ISBN 978-0-07138076-0. |
| 60/83 | US=86 / Biol/Mol Melet A, Song K, Bucur O, Jagani Z, Grassian AR, Khosravi-Far R. Apoptotic pathways in tumor progression and therapy. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 47-79. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. VIAS APOPTOTICAS; PROGRESSAO TUMORAL; TERAPIA DE CANCER; APOPTOSE; INIBIDORES; TRANSDUCAO DE SINAL; ONCOGENE; MAQUINARIA APOPTOTICA; DROGAS QUIMIOTERAPICAS; RESISTENCIA A DROGA |